|
" Cancer imaging / "
edited by M.A. Hayat.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
1027938
|
| Doc. No
|
:
|
b782308
|
| Title & Author
|
:
|
Cancer imaging /\ edited by M.A. Hayat.
|
| Publication Statement
|
:
|
Amsterdam ;Boston :: Elsevier, Academic Press,, ©2008-
|
| Series Statement
|
:
|
Cancer imaging
|
| Page. NO
|
:
|
volumes :: illustrations (some color) ;; 29 cm.
|
| ISBN
|
:
|
0123704685
|
|
|
:
|
: 0123741831
|
|
|
:
|
: 0123742129
|
|
|
:
|
: 9780123704689
|
|
|
:
|
: 9780123741837
|
|
|
:
|
: 9780123742124
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and indexes.
|
| Contents
|
:
|
Axillary lymph node status in breast cancer: pinhole collimator single-photon emission computed tomography -- Detection of small-size primary breast cancer: ⁹⁹mTc-tetrofosmin single photon emission computed tomography -- Microcalcification in breast lesion: radiography and histopathology -- Benign and malignant breast lesions: doppler sonograpy -- Response to neoadjuvant treatment in patients with locally advanced brest cancer: color-doppler ultrasound contrast medium (levovist) -- Magnetic resonance spectroscopy of breast cancer: current techniques and clinical applications -- Breast scintigraphy -- Primary breast cancer: false-negative and false-positive bone scintigraphy -- Improved sensitivity and specificity of breast cancer thermography -- Optical mammography -- Digital mammography -- Screening for breast cancer in women with a familial or genetic predisposition: magnetic resonance imaging versus mammography -- Mammographic screening: impact on survival -- False-positive mammography examinations -- Breast dose in thoracic computed tomography -- Absorbed dose measurement in mammography -- Metastatic choriocarcinoma to the breast: mammography and color doppler ultrasound -- Detection and characterization of breast lesions: color-coded signal intensity curve software for magnetic resonance-based breast imaging -- Detection of breast malignancy: different magnetic resonance imaging modalities -- Breast lesions: computerized analysis of magnetic resonance imaging -- Optical imaging techniques for breast cancer -- Magnetic resonance imaging: measurements of breast tumor volume and vascularity for monitoring response to treatment -- Defining advanced breast cancer: ¹⁸F-fluorodeoxyglucose-positron emission tomography -- Leiomyoma of the breast parenchyma: mammographic, sonographic, and histopathologic features -- Detection of breast cancer: dynamic infrared imaging -- Phyllodes breast tumors: magnetic resonance imaging.
|
|
|
:
|
Potential new staging perspectives in colorectal cancer: whole-body PET/CT-colonography -- Thoracic esophageal cancer: interstitial magnetic lymphography using superparamagnetic iron -- Esophageal cancer; comparsion of ¹⁸F-fluoro-3deoxy-3-[L]-fluorothymidine-positron emission tomography with ¹⁸f-fluorodeoxyglucose-positron emission tomography -- Gastrointestinal stromal tumors: positron emission tomography and contrast-enhanced helical computed tomography -- Gastrointestinal stromal tumor: computed tomography -- Gastrointestinal lipomas: computed tomography -- Computed tomography in peritoneal surface malignancy -- Gastrointestinal tumors: computed tomography/endoscopic ultrasonography -- Magnetic resonance cholangiopancreatography -- Occult primary head and neck carcinoma: role of positron emission tomography imaging -- Benign and malignant nodes in the neck: magnetic resonance microimaging -- Oral squamous cell carcinoma: comparison of computed tomography with magnetic resonance imaging -- Computed tomography in renal cell carcinoma -- Renal cell carcinoma subtypes: multislice computed tomography -- Renal impairment: comparison of noncontrast computed tomography, magnetic resonance urography, and combined abdominal radiography/ultrasonography -- Renal lesions: magnetic resonance diffusion-weighted imaging -- Malignant lymphoma: ¹⁸F-fluorodeoxyglucose-positron emission tomography -- Malignant melanoma: positron emission tomography -- Multiple myeloma: scintigraphy using technetium-99m-2-methoxyisobutylisonitrile -- Nasopharyngeal carcinoma: ¹⁸F-fluorodexyglucose-positron emission tomography -- Nasopharyngeal carcinoma for staging and restaging with ¹⁸F-FDG-PET/CT -- Ovarian sex cord stromal tumors: computed tomography and magnetic resonance imaging -- Malignant germ cell tumors: computed tomography and magnetic resonance imaging -- Ovarian small round cell tumors: magnetic resonance imaging -- Ovarian borderline serous surface papillary tumor: magnetic resonance imaging -- Chronic pancreatics versus pancreatic cancer: positron emission tomography -- Pancreatic cancer: P-[¹²³l] lodo-L-phenylalanine single photon emission tomography for tumor imaging -- Pancreatic islet cell tumors: endoscopic ultrasonography -- Parotid gland tumors: advanced imaging technologies -- Pituitary macroadenomas: intraoperative magnetic resonance imaging and endonasal endoscopy -- Penile cancer staging: ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography -- Malignant peripheral nerve sheath tumors: [¹⁸F]fluorodeoxyglucose-positron emission tomography -- Prostate cancer: ¹¹C-choline-positron emission tomography -- Metabolic characterization of prostate cancer: magnetic resonance spectroscopy -- Prostate cancer: diffusion-weighted imaging -- Prostatic secretory protein of 94 amino acids, gene-directed transgenic prostate cancer: three-dimensional ultrasound microimaging -- Prostate cancer within the transition zone: gadolinium-enhanced magnetic resonance imaging -- Rectal wall invasion of locally advanced prostate cancer: comparison of magnetic resonance imaging with transrectal ultrasound -- Local staging of prostate cancer using endorectal coil magnetic resonance imaging -- Extremity sarcoma: positron emission tomography -- Retroperitoneal synovial sarcoma: color-doppler ultrasound, computed tomography, and magnetic resonance imaging -- Thymona: computed tomography -- Hemolymphangiomatosis of the spleen: conventional diagnostic imaging and magnetic resonance imaging with superparamagnetic contrast agent -- Thyroid cancer: ¹⁸F-FDG-positron emission tomography -- Thyroid cancer: ¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography (an overview) -- Diagnosis of thyroid cancer in children: value of power doppler ultrasound.
|
|
|
:
|
V. 1: Strategies for imaging biology in cancer and other diseases -- Synthesis of ¹⁸F-fluoromisonidazole tracer for positron emission tomography -- Radiation hormesis -- Molecular imaging in early therapy monitoring -- Positron emission tomography in medicine: an overview -- Radiation dose and image quality -- Contrast agents for magnetic resonance imaging: an overview -- Whole-body computed tomography screening -- Whole-body ¹⁸F-fluorodeoxyglucose-positron emission tomography: is it valuable for health screening? -- Staging solid tumors with ¹⁸F-fluorodexoyglucose-positron emission tomography/computed tomography -- Laser doppler perfusion imaging: clinical diagnosis -- Dynamic sonographic tissue perfusion measurement with the pixelflux method -- Immuno-positron emission tomography -- Role of imaging biomarkers in drug development -- The role of imaging in lung cancer -- Lung cancer staging: integrated ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography and computed tomography alone -- Computed tomography screening for lung cancer -- Lung cancer: role of multislice computed tomography -- Surgically resected pleomorphic lung carcinoma: computed tomography -- Lung cancer: low dose helical computed tomography -- Lung cancer: computer-aided diagnosis with computed tomography -- Stereotactic radiotherapy for non-small lung carcinoma computed tomography -- Thin-section computed tomography correlates with clinical outcome in patients with mucin-producing adenocarcinoma of the lung -- Non-small lung carcinoma: ¹⁸F-fluorodeoxyglucose-positron emission tomography -- Evaluating positron emission tomography in non-small cell lung cancer: moving beyond accuracy to outcome -- Non-small cell lung cancer: false-positive results with ¹⁸F-fluorodeoxyglucose-positron emission tomography -- Oxygen-enhanced proton magnetic resonance imaging of the human lung -- Detection of pulmonary gene transfer using iodide-124/positron emisson tomography -- Lung cancer with idiopathic pulmonary fibrosis: high-resolution computed tomography -- Categorization of mammographic density for breast cancer: clinical significance -- Breast tumor classification and visualization with machine-learning approaches -- Mass detection scheme for digitized mammography -- Full-field digital phase-contrast mammography -- Full-field digital mammography versus film-screen mammography -- Use of contrast-enhanced magnetic resonance imaging for detecting invasive lobular carcinoma.
|
|
|
:
|
V. 2: Proton computed tomography -- Multidetector computed tomography -- Megavoltage computed tomography imaging -- Integrated set-3000G/X positron emission tomography scanner -- High-resolution magic angle spinning magnetic resonance spectroscopy -- Spatial dependency of noise and its correlation among various imaging modalities -- Computed tomography scan methods account for respiratory motion in lung cancer -- Respiratory motion artifact using positron emission tomography/computed tomography -- Gadolinium-based contrast media used in magnetic resonance imaging: an overview -- Molecular imaging of cancer with superparamagnetic iron-oxide nanoparticles -- Adverse reactions to iodinated contrast media -- The accuracy of diagnostic radiology -- Diffraction-enhanced imaging: applications to medicine -- Role of imaging in drug development -- Characterization of multiple aspects of tumor physiology by multitracer positron emission tomography -- Whole-body magnetic resonance imaging in patients with metastases -- Whole-body imaging in oncology: positron emission tomography/computed tomography (PET/CT) -- Whole-body cancer imaging: simple image fusion with positron emission tomography/computed tomography -- Whole body tumor imaging: O-[¹¹C]methyl-L-tyrosine/positron emission tomography -- Tumor proliferation 2-[¹¹C]-thymidine positron emission tomography -- ¹⁸F-fluorodeoxyglucose-positron emission tomography in oncology: advantages and limitations -- Positron emission tomography imaging of tumor hypoxia and angiogenesis: imaging biology and guiding therapy -- Noninvasive determination of angiogenesis: molecular targets and tracer development -- Gross tumor volume and clinical target volume: anatomical computed tomography and functional FDG-PET -- Post-treatment changes in tumor microenvironment: dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging -- In vivo molecular imaging in oncology: principles of reporter gene expression imaging -- Medical radiation-induced cancer -- Adrenal lesions: role of computed tomography, magnetic resonance imaging, ¹⁸F-fluorodeoxyglucose-positron emission tomography, and positron emission tomography/computed tomography -- Hemangioendothelioma: whole-body technetium-99m red blood cell imaging-magnetic resonance imaging -- Malignant bone involvement: assessment using positron emission tomography/computed tomography -- Bone metastasis: single photon emission computed tomography/computed tomography -- Bone cancer: comparison of ¹⁸F-fluorodeoxyglucose-positron emission tomography with single photon emission computed tomography -- Bone metastasis in endemic nasopharyngeal carcinoma: ¹⁸F-fluorodeoxyglucose-positron emission tomography -- Colorectal polyps: magnetic resonance colonography -- Early bile duct carcinoma: ultrasound, computed tomography, cholangiography, and magnetic resonance cholangiography -- Incidental extracolonic lesions: computed tomography -- Colorectal cancer: magnetic resonance imaging-cellular and molecular imaging.
|
| Abstract
|
:
|
These two volumes present readers with the most up-to-date imaging instrumentation, general and diagnostic applications for various cancers. Both volumes discuss the various imaging techniques used to locate and diagnose tumors, including ultrasound, X-ray, color Doppler sonography, PET, CT, PET/CT, MRI, SPECT, diffusion tensor imaging, dynamic infrared imaging, and magnetic resonance spectroscopy. They also detail strategies for imaging cancer, emphasizing the importance of the use of this technology for clinical diagnosis. Imaging techniques that predict the malignant potential of cancers, response to chemotherapy and other treatments, recurrence, and prognosis are also detailed.
|
| Subject
|
:
|
Cancer-- Imaging.
|
| Subject
|
:
|
Cancer-- Imaging.
|
| Subject
|
:
|
Bildgebendes Verfahren.
|
| Subject
|
:
|
Brustkorb.
|
| Subject
|
:
|
Krebs Medizin
|
| Subject
|
:
|
Lunge.
|
| Subject
|
:
|
Diagnostic Imaging-- methods.
|
| Subject
|
:
|
Neoplasms-- diagnosis.
|
| Subject
|
:
|
Breast Neoplasms-- diagnosis.
|
| Subject
|
:
|
Diagnostic Imaging-- instrumentation.
|
| Subject
|
:
|
Lung Neoplasms-- diagnosis.
|
| Dewey Classification
|
:
|
616.99/4240754
|
|
|
:
|
616.99/40754
|
| LC Classification
|
:
|
RC280.L8C34 2008
|
| NLM classification
|
:
|
2008 D-698
|
|
|
:
|
QZ 241C2144 2008
|
| Added Entry
|
:
|
Hayat, M. A.,1940-
|
| |